Safety and Efficacy Study of Bendamustine to Treat Non-Hodgkin Lymphoma
Clinical trial NCT01570049 · UNKNOWN
Trial details
- NCT number
- NCT01570049
- Sponsor
- Shandong Lanjin Pharmaceuticals Co.,Ltd
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-04-01
- Primary completion
- 2012-09-01
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.